PolyMag Result s

Magnetofection™ is a novel, simple and highly efficient method to transfect cells in culture and in vivo. It exploits magnetic force exerted upon gene vectors associated with magnetic particles to drive the vectors towards, possibly even into, the target cells. In this manner, the complete applied vector dose gets concentrated on the cells within a few minutes so that 100% of the cells get in contact with a significant vector dose.

This has several important consequences: 1. Greatly improved rates in terms of percentage of cells transfected compared to standard . 2. Up to several thousand folds increased levels of transgene expression compared to standard transfections. 3. High transfection rates and transgene expression levels are achievable with extremely low vector doses, which allow saving expensive transfection reagents. 4. Extremely short process time in comparison to standard procedures. A few minutes of incubation of cells with gene vectors are sufficient to generate high transfection efficiency.

OZ Biosciences offers three types of ready-to-use reagents: SilenceMag specific to siRNA delivery, CombiMag designed to be associated with all vectors: transfection reagents and and PolyMag . PolyMag has been designed and used successfully to deliver all types of nucleic acids such as plasmid DNA, RNA, Oligonucleotides & siRNA. PolyMag is a universally applicable magnetic particle preparation for high transfection efficiency. Nucleic acids to be transfected and the magnetic particles are mixed in a one-step procedure.

Nucleic Acid Types

Nucleic Acid or Type PolyMag SilenceMag CombiMag DNA (plasmid) √ NA √ Oligonucleotides √ ND √ mRNA √ ND √ siRNA √ √ √ dsRNA ND √ √ shRNA ND √ √ Adenovirus NA NA √ Retro virus NA NA √

Cell Types

PolyMag is generally applicable on numerous types. This technology has been tested successfully on a variety of immortalized and primary cells. Please consult our updated list of cells successfully tested available on the website: www.ozbiosciences.com . If a particular cell type or cell line is not listed, this does not imply that PolyMag is not going to work. OZ Biosciences is going to frequently adjust this list.

OZ Biosciences – PolyMag Results Page 1 of 5

Transfec tion of Primary Cells

Standard Transfection Magnetofection 

Confluent Primary Human Keratinocytes Transfected with a commercial reagent L or PolyMag Reporter Gene: GFP

We are grateful to the laboratories of Dr. C. Plank (Technical University, Munich) for kindly providing these data.

50 Primary Porcine Aortic Endothelial Cells PolyMagMagnetofecti Transfected with a commercial reagent P or 40 Reagent(PolyMa P PolyMag Standard Reporter Gene: GFP (PEI) Culture dish: 96-well plate 30

We are thankful to Dr. F. Kroetz (Ludwig- 20 Maximilians University, Munich) for nicely providing these data. 10

0

DNA dose (ng)

Transfection of Cell Lines

Standard Transfection Magnetofection 

CT -26 Colon Carcinoma / Mouse

Transfected with a commercial reagent

D or PolyMag DNA Reporter Gene: GFP 0.15 µg Culture dish: 24-well plate

We are grateful to the laboratories of

Dr. C. Plank (Technical University,

Munich) for kindly providing these data.

DNA 0.3 µg

OZ Biosciences – PolyMag Results Page 2 of 5 Various examples of PolyMag transfection efficiency (24-well plate; 0.5 l PolyMag & 0.5g DNA/ well):

COS 7 N2A Hep2 HeLa

Monkey Kidney Fibroblast Mouse Neuroblastoma Human Epithelial Human Epithelial Carcinoma

PolyMag Transfection Efficiency

100% 90%

85% 80% 90%

80% 75% 75% 70% 70%

60% 55% 50% 50%

50%

40%

30% transfection% efficiency 20%

10%

0% 293 BHK-21 CHO COS7 CT-26 HaCaT HT1080 MCF-7 N2A

Cells

Improved and Optimized PolyMag Formulation

OZ Biosciences has developed a new very efficient PolyMag formulation for Magnetofection TM . This improved PolyMag II reagent gives reliable higher transfection efficiencies in numerous cell types (see figures), transports all type of nucleic acids (DNA, siRNA, ODN). This PolyMag optimized formulation is the actual commercialized PolyMag reagent. Most of the herein described results were obtained with the new optimized PolyMag formulation.

Transfection efficiency PolyMag - HaCaT cells

1200

1000 PolyMag I PolyMag II 800 We are thankful to Dr. L. Journot (CNRS - UPR2580, Montpellier) for nicely providing 600 these data. 400

200

Luciferase(count/s) activity 0 2 4 8 µg pRSV -Luc/plate

OZ Biosciences – PolyMag Results Page 3 of 5

Delivery of Oligonucleotides

Standard Transfection Magnetofection  HUVEC -C (Primary) / Human Transfected with a commercial reagent E or PolyMag Fluorescent Oligonucleotides Culture dish: 24-well plate ODN: 200 ng / well

We are grateful to Dr. F. Kroetz (Ludwig- Maximilians University, Munich) for kindly providing these data.

siRNA Delivery Efficiency

GFP stably transfected HeLa cells .

Target siRNA : GFP Cell culture dish : 96-well plate Transfection volume : 200 l.

Control PolyMag + siRNA/10nM PolyMag + siRNA/40nM

Primary Human Umbilical Vein Endothelial Ce lls TF # 1 Gene Silencing mediated by PolyMag/siRNA (HUVEC). Target siRNA : Transcription factor # 1 100 90

Control siRNA : Transcription factor # 2 (Belongs to TF#1 family) 80 70 Control siRNA : GFP 60 50 Cell culture dish : 60 mm 40

Normalized 30 SiRNA final concentration: 25nM (2x treatments) expression unit 20 10 We are grateful to Dr. D. Mathieu (CNRS- 0 GFP TF#1 TF#2 TF #1 Control UMR5535, Montpellier) for kindly providing these + # 2 data . siRNA

OZ Biosciences – PolyMag Results Page 4 of 5

Cytotoxicity Electroporation vs. Magnetofection

100 90

80 70 60 50 transfection - 40

% of% cells living 30 post 20

10 0 Electroporation PolyMag

Bibliographic References

Please consult our list of references available on the website: www.ozbiosciences.com .

OZ Biosciences – PolyMag Results Page 5 of 5